Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Watch: ARWR, COLL, NVCR, SPWR

Published 01/11/2018, 11:53 PM
Updated 07/09/2023, 06:31 AM

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is a recent new swing trade, which is acting great. It moved nicely after coming out of the falling channel. It spiked, pulled back in a falling wedge, and on Thursday it broke out, popping 64 cents, or 15%, to 5.04, on 4.9 million shares traded. Targets going forward are 6, and then 8.

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) finally broke out of the wedge with a pop of 1.38, or 7.3%, to 20.29, on 858,336 shares traded. That’s the best volume in a month. For me, if it gets through the double-top at 20.90-21.00, it will run to 23-4, and it may go higher than that. A big short position is at 22-24.

NovoCure Limited (NASDAQ:NVCR) has a new swing put on it. We gave you one back in April. I’ve been watching this stock for months while it was consolidating, it got narrow, and on Wednesday it started to pop, on Thursday it followed through gaining 65 cents, or 3%, to 22.15, on 3.5 million shares traded. It didn’t close great, although it did close above the breakout point. Let’s see if there’s a follow-through on Friday. The volume was huge on Thursday. Targeting 25 1/2-6, and then 29.

SunPower Corporation (NASDAQ:SPWR) is one of the solar stocks that did well today. It jumped 98 cents, or 11 1/2%, to 9.47, on 6.2 million shares traded. Obviously, in July when it ran up, and then came down, it retested. It has a full pattern, which is one big base. In order to make a long-term move, it has to take out 9 3/4, and then I’ll be looking at 11 1/2. My secondary target is 13 3/4-14.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On the long side, stocks included Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), Abercrombie & Fitch Co. (NYSE:ANF), Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), Cheetah Mobile Inc. (NYSE:CMCM), Collegium Pharmaceutical, Inc. (NASDAQ:COLL), California Resources Corporation (NYSE:CRC), CARBO Ceramics Inc. (NYSE:CRR), First Solar, Inc. (NASDAQ:FSLR), Fusion Telecommunications International, Inc. (NASDAQ:FSNN), GlycoMimetics, Inc. (NASDAQ:GLYC), GRIDSUM HOLDING INC. (NASDAQ:GSUM), Kush Bottles, Inc. (OTC:KSHB), Remark Holdings, Inc. (NASDAQ:MARK), Mirati Therapeutics, Inc. (NASDAQ:MRTX), NovoCure Limited (NASDAQ:NVCR), Pixelworks, Inc. (NASDAQ:PXLW), SunPower Corporation (NASDAQ:SPWR), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Trupanion, Inc. (NASDAQ:TRUP), U.S. Gold Corp. (NASDAQ:USAU), ViewRay, Inc. (NASDAQ:VRAY), and W&T Offshore Inc. (NYSE:WTI).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.